Bedminster-based Aerie Pharmaceuticals Inc. announced today the pricing of its initial public offering of 6.72 million shares of its common stock at a public offering price of $10 per share. The offering totals $67.2 million, before underwriting discounts.
According to the announcement, the shares are scheduled to begin trading on Nasdaq today under the ticker symbol AERI. The company has granted the underwriters a 30-day option to purchase up to an additional 1 million shares of common stock at the same price to cover over-allotments, if any. The offering is expected to close Oct. 30, subject to customary closing conditions.
The company first filed its IPO registration in September.